ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
2.040
-0.050 (-2.39%)
At close: Oct 29, 2024, 4:00 PM
2.020
-0.020 (-0.98%)
After-hours: Oct 29, 2024, 5:50 PM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $2.19 million as of October 29, 2024. Its market cap has decreased by -45.22% in one year.
Market Cap
2.19M
Enterprise Value
2.07M
1-Year Change
-45.22%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since December 21, 2021, ZyVersa Therapeutics's market cap has decreased from $96.70M to $2.19M, a decrease of -97.73%. That is a compound annual growth rate of -73.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 2.20M | -48.84% |
| Dec 29, 2023 | 4.30M | -75.00% |
| Dec 30, 2022 | 17.20M | -82.29% |
| Dec 31, 2021 | 97.10M | 0.41% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 2.45M |
| Sintx Technologies | 2.44M |
| Salarius Pharmaceuticals | 2.41M |
| Scorpius Holdings | 2.27M |
| Tharimmune | 2.27M |
| Dermata Therapeutics | 2.20M |
| Allarity Therapeutics | 2.13M |
| IMAC Holdings | 2.10M |